BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28716439)

  • 1. Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma.
    Sirohi D; Smith SC; Ohe C; Colombo P; Divatia M; Dragoescu E; Rao P; Hirsch MS; Chen YB; Mehra R; Amin MB
    Hum Pathol; 2017 Sep; 67():134-145. PubMed ID: 28716439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic Challenges.
    Lai JZ; Lai HH; Cao D
    Anticancer Res; 2018 Jun; 38(6):3757-3761. PubMed ID: 29848739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma.
    Ohe C; Smith SC; Sirohi D; Divatia M; de Peralta-Venturina M; Paner GP; Agaimy A; Amin MB; Argani P; Chen YB; Cheng L; Colecchia M; Compérat E; Werneck da Cunha I; Epstein JI; Gill AJ; Hes O; Hirsch MS; Jochum W; Kunju LP; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Nesi G; Osunkoya AO; Picken MM; Rao P; Reuter VE; de Oliveira Salles PG; Schultz L; Tickoo SK; Tomlins SA; Trpkov K; Amin MB
    Am J Surg Pathol; 2018 Mar; 42(3):279-292. PubMed ID: 29309300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship.
    Gupta R; Billis A; Shah RB; Moch H; Osunkoya AO; Jochum W; Hes O; Bacchi CE; de Castro MG; Hansel DE; Zhou M; Vankalakunti M; Salles PG; Cabrera RA; Gown AM; Amin MB
    Am J Surg Pathol; 2012 Sep; 36(9):1265-78. PubMed ID: 22895263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of renal cell carcinoma unclassified with medullary phenotype without detectable gene deletion.
    Tsuzuki S; Kataoka TR; Ito H; Ueshima C; Asai S; Yokoo H; Haga H
    Pathol Int; 2019 Dec; 69(12):710-714. PubMed ID: 31617267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature.
    Zhao M; Teng X; Ru G; Zhao Z; Hu Q; Han L; He X
    Int J Clin Exp Pathol; 2015; 8(9):11124-31. PubMed ID: 26617832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal medullary carcinoma in a young mixed-race man in Japan.
    Toriyama A; Izumi H; Tomita S; Nagashima Y; Ueda Y; Aoki Y; Tsujimura A; Yao T; Hino O
    Pathol Int; 2019 Apr; 69(4):241-245. PubMed ID: 30843648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.
    Msaouel P; Hong AL; Mullen EA; Atkins MB; Walker CL; Lee CH; Carden MA; Genovese G; Linehan WM; Rao P; Merino MJ; Grodman H; Dome JS; Fernandez CV; Geller JI; Apolo AB; Daw NC; Hodges HC; Moxey-Mims M; Wei D; Bottaro DP; Staehler M; Karam JA; Rathmell WK; Tannir NM
    Clin Genitourin Cancer; 2019 Feb; 17(1):1-6. PubMed ID: 30287223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collision renal cell papillary and medullary carcinoma in a 66-year-old man.
    Lam ET; Kessler ER; Flaig TW; La Rosa FG
    Oncology (Williston Park); 2013 Sep; 27(9):893, 896, 898. PubMed ID: 24282987
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes.
    Gatalica Z; Lilleberg SL; Monzon FA; Koul MS; Bridge JA; Knezetic J; Legendre B; Sharma P; McCue PA
    Hum Pathol; 2011 Dec; 42(12):1979-88. PubMed ID: 21733559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High grade infiltrative adenocarcinomas of renal cell origin: New insights into classification, morphology, and molecular pathogenesis.
    Singh JA; Ohe C; Smith SC
    Pathol Int; 2018 May; 68(5):265-277. PubMed ID: 29665139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytology of metastatic renal medullary carcinoma in pleural effusion: a study of two cases.
    Ellis CL; Burroughs F; Michael CW; Li QK
    Diagn Cytopathol; 2009 Nov; 37(11):843-8. PubMed ID: 19526572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMARCB1/INI1 inactivation in renal medullary carcinoma.
    Calderaro J; Moroch J; Pierron G; Pedeutour F; Grison C; Maillé P; Soyeux P; de la Taille A; Couturier J; Vieillefond A; Rousselet MC; Delattre O; Allory Y
    Histopathology; 2012 Sep; 61(3):428-35. PubMed ID: 22686875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of renal medullary carcinoma in children and young adults: a report from the Children's Oncology Group.
    Sandberg JK; Mullen EA; Cajaiba MM; Smith EA; Servaes S; Perlman EJ; Geller JI; Ehrlich PF; Cost NG; Dome JS; Fernandez CV; Khanna G
    Pediatr Radiol; 2017 Nov; 47(12):1615-1621. PubMed ID: 28689245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Renal Medullary Carcinoma.
    Su Y; Hong AL
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear cell renal cell carcinoma (ccRCC) with hemangioblastoma-like features: a previously unreported pattern of ccRCC with possible clinical significance.
    Montironi R; Lopez-Beltran A; Cheng L; Galosi AB; Montorsi F; Scarpelli M
    Eur Urol; 2014 Nov; 66(5):806-10. PubMed ID: 24821578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases.
    Jia L; Carlo MI; Khan H; Nanjangud GJ; Rana S; Cimera R; Zhang Y; Hakimi AA; Verma AK; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE; Gartrell BA; Chen YB
    Mod Pathol; 2019 Sep; 32(9):1329-1343. PubMed ID: 30980040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Unclassified Renal Cell Carcinoma With Medullary Phenotype and
    Valeri M; Cieri M; Elefante GM; De Carlo C; Rudini N; Lughezzani G; Buffi NM; Terracciano LM; Colombo P
    Front Med (Lausanne); 2022; 9():835599. PubMed ID: 35198580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.